Literature DB >> 9294175

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex.

J M Trowbridge1, I Rogatsky, M J Garabedian.   

Abstract

We have found that ectopic expression of cyclin A increases hormone-dependent and hormone-independent transcriptional activation by the estrogen receptor in vivo in a number of cell lines, including HeLa cells, U-2 OS osteosarcoma cells and Hs 578Bst breast epithelial cells. This effect can be further enhanced in HeLa cells by the concurrent expression of the cyclin-dependent kinase activator, cyclin H, and cdk7, and abolished by expression of the cdk inhibitor, p27(KIP1), or by the expression of a dominant negative catalytically inactive cdk2 mutant. ER is phosphorylated between amino acids 82 and 121 in vitro by the cyclin A/cdk2 complex and incorporation of phosphate into ER is stimulated by ectopic expression of cyclin A in vivo. Together, these results strongly suggest a direct role for the cyclin A/cdk2 complex in phosphorylating ER and regulating its transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294175      PMCID: PMC23327          DOI: 10.1073/pnas.94.19.10132

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

Authors:  P Tan; B Cady; M Wanner; P Worland; B Cukor; C Magi-Galluzzi; P Lavin; G Draetta; M Pagano; M Loda
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

2.  A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells.

Authors:  M J Sleigh
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

3.  Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.

Authors:  F L Hall; R T Williams; L Wu; F Wu; D A Carbonaro-Hall; J W Harper; D Warburton
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

4.  A link between cyclin A expression and adhesion-dependent cell cycle progression.

Authors:  T M Guadagno; M Ohtsubo; J M Roberts; R K Assoian
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

5.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.

Authors:  P Le Goff; M M Montano; D J Schodin; B S Katzenellenbogen
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

6.  Structure and cell cycle-regulated transcription of the human cyclin A gene.

Authors:  B Henglein; X Chenivesse; J Wang; D Eick; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 7.  Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.

Authors:  B S Katzenellenbogen; B Bhardwaj; H Fang; B A Ince; F Pakdel; J C Reese; D Schodin; C K Wrenn
Journal:  J Steroid Biochem Mol Biol       Date:  1993-12       Impact factor: 4.292

8.  Expression and amplification of cyclin genes in human breast cancer.

Authors:  M F Buckley; K J Sweeney; J A Hamilton; R L Sini; D L Manning; R I Nicholson; A deFazio; C K Watts; E A Musgrove; R L Sutherland
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

Review 9.  Oncogenic activation of cyclin A.

Authors:  C Bréchot
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

10.  Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.

Authors:  S Ali; D Metzger; J M Bornert; P Chambon
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  23 in total

Review 1.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 3.  Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.

Authors:  Nicole L Moore; Ramesh Narayanan; Nancy L Weigel
Journal:  Steroids       Date:  2007-01-04       Impact factor: 2.668

Review 4.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

5.  Regulation of hormonal therapy resistance by cell cycle machinery.

Authors:  Binoj Chandrasekharan Nair; Ratna K Vadlamudi
Journal:  Gene Ther Mol Biol       Date:  2008-01-01

Review 6.  Antiestrogens--tamoxifen, SERMs and beyond.

Authors:  K Dhingra
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.

Authors:  J Cui; Y Yang; H Li; Y Leng; K Qian; Q Huang; C Zhang; Z Lu; J Chen; T Sun; R Wu; Y Sun; H Song; X Wei; P Jing; X Yang; C Zhang
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

8.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Tamoxifen-stimulated growth of breast cancer due to p21 loss.

Authors:  Abde M Abukhdeir; Michele I Vitolo; Pedram Argani; Angelo M De Marzo; Bedri Karakas; Hiroyuki Konishi; John P Gustin; Josh Lauring; Joseph P Garay; Courtney Pendleton; Yuko Konishi; Brian G Blair; Keith Brenner; Elizabeth Garrett-Mayer; Hetty Carraway; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

10.  The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.

Authors:  N C Wortham; E Ahamed; S M Nicol; R S Thomas; M Periyasamy; J Jiang; A M Ochocka; S Shousha; L Huson; S E Bray; R C Coombes; S Ali; F V Fuller-Pace
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.